During the past decade, South Bend Clinic conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 108 clinical trials were completed, i.e. on average, 514.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 37 clinical trials were completed. i.e. 616.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Bend Clinic" #1 sponsor was "National Cancer Institute (NCI)" with 46 trials, followed by "Alliance for Clinical Trials in Oncology" with 33 trials sponsored, "Gynecologic Oncology Group" with 11 trials sponsored, "Eli Lilly and Company" with 9 trials sponsored and "SWOG Cancer Research Network" with 9 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Bend Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 64 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "NCIC Clinical Trials Group" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 24 different institutions and companies that were collaborators in the rest 24 trials.

According to Clinical.Site data, the most researched conditions in "South Bend Clinic" are "Breast Cancer" (18 trials), "Psoriasis" (9 trials), "Stage IV Fallopian Tube Cancer AJCC v6 and v7" (8 trials), "Stage IV Ovarian Cancer AJCC v6 and v7" (8 trials) and "Lung Cancer" (7 trials). Many other conditions were trialed in "South Bend Clinic" in a lesser frequency.

Most popular intervention types in "South Bend Clinic" are "Drug" (128 trials), "Other" (75 trials), "Biological" (51 trials), "Procedure" (18 trials) and "Radiation" (13 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (42 trials), "Quality-of-Life Assessment" (29 trials), "Placebo" (25 trials), "Paclitaxel" (24 trials) and "Bevacizumab" (22 trials). Other intervention names were less common.

The vast majority of trials in "South Bend Clinic" are 105 trials for "All" genders, 46 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "South Bend Clinic". undefined are not yet recruiting, undefined are recruiting, 39 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 99 completed trials in South Bend Clinic, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in South Bend Clinic, 4 "Phase 1" clinical trials were conducted, 51 "Phase 2" clinical trials and 93 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".